The global push for precision medicine has placed a spotlight on the Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Share, as stakeholders across the diagnostic value chain compete to provide the most accurate genomic visualization tools. With the market projected to reach US$ 1,901.4 million by 2030, the battle for market dominance is being fought on the fronts of software...